Journals / Erciyes Tıp Dergisi / 2010 / Cilt: 32 - Sayı: 1

Anesthetic management of a patient with myasthenia gravis

Miyastenia gravis'li olguda anestezi yönetimi

Pages
49–52
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this case report is to review to anesthetic management of a patient with myasthenia gravis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myasthenia Gravis is an autoimmune disorder in which the patients produce antibodies that attach the nicotinic acetylcholine receptors at the neuromuscular junction.
📊
Key Findings & Data:The interactions between myorelaxants, anticholinesterases or the other drugs that are used in general anesthesia can cause postoperatif respiratuary failure.
💡
Conclusion & Impact:The purpose of this case report is to review to anesthetic management of a patient with myasthenia gravis.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Myasthenia Gravis is an autoimmune disorder in which the patients produce antibodies that attach the nicotinic acetylcholine receptors at the neuromuscular junction. The interactions between myorelaxants, anticholinesterases or the other drugs that are used in general anesthesia can cause postoperatif respiratuary failure. Regional anesthesia have been suggested for the lower abdominal and extremity operations. The purpose of this case report is to review to anesthetic management of a patient with myasthenia gravis.

Özet

Miyastenia Gravis sinir kas kavşağındaki nikonitik asetilkolin reseptörlerine karşı, hasta tarafından geliştirilen antikorlar ile oluşan otoimmün bir hastalıktır. Genel anestezide kullanılan kas gevşeticiler, antikolinesterazlar ya da diğer ilaç etkileşimlerine bağlı postoperatif solunum yetmezliği gelişebilir. Alt batın ve ekstremite ameliyatları için rejyonel anestezi tercih edilir. Bu olgu sunumunun amacı, Miyastenia Gravis’li olguda anestezik yaklaşımını gözden geçirmektir.

🔖

Cite This Article

BAYRAM, A., ARTIŞ, T., YEĞENOĞLU, F., ÇORUH, A. E. (2022). Anesthetic management of a patient with myasthenia gravis. Erciyes Tıp Dergisi, Cilt: 32 - Sayı: 1, 49–52. https://ajindex.com/articles/502557

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Esener Z. Klinik Anestezi. 2.Baskı, İstanbul; Logos Yayıncılık: 1997. s.610-611
  2. Book WJ, Abel M, Eisenkraft JB. Anesthesia and neuromuscular diseases. Anesthesiol Clin North America 1996;14:515-542 3) Kiran U, Choudhury M, Saxena N, Kapoor P. Sevoflurane as a sole anaesthetic agent for thymectomy in myasthenia gravis. Acta Anaesthesiol Scand 2000; 44:351-353
  3. Abel M, Eisenkraft JB. Anesthetic implications of myasthenia gravis. Mt Sinai J Med 2002; 69:31-37
  4. Morgan GE. Mikhail MS, Murray MJ (eds). Clinical Anestesiology (4th ed). McGraw-Hill, 2008, pp. 818 – 819
  5. Morgan GE, Mikhail MS, Murray MJ (eds). Local Anesthetics In: Clinical Anesthesiology. (3nd ed). McGraw Hill, USA 2004; pp. 233-242
  6. Barrons RW. Drug-induced neuromuscular blockade and myasthenia gravis. Pharmacotherapy 1997; 17:1220–1232
  7. Lake CL. Curare sensitivity in steroid treated myasthenia gravis: A case report. Anesth Analg 1978; 57:132–134.